Vietnam · Delayed Price · Currency is VND Ligand Pharmaceuticals Statistics
Total Valuation
HNX:HHC has a market cap or net worth of VND 1.64 trillion. The enterprise value is 1.75 trillion.
| Market Cap | 1.64T |
| Enterprise Value | 1.75T |
Important Dates
The last earnings date was Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HNX:HHC has 16.43 million shares outstanding.
| Current Share Class | 16.43M |
| Shares Outstanding | 16.43M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 13.43M |
Valuation Ratios
The trailing PE ratio is 37.12.
| PE Ratio | 37.12 |
| Forward PE | n/a |
| PS Ratio | 2.13 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.92, with an EV/FCF ratio of -25.88.
| EV / Earnings | 39.61 |
| EV / Sales | 2.27 |
| EV / EBITDA | 43.92 |
| EV / EBIT | 76.49 |
| EV / FCF | -25.88 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.34 |
| Quick Ratio | 2.10 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 4.39 |
| Debt / FCF | -2.59 |
| Interest Coverage | 0.50 |
Financial Efficiency
Return on equity (ROE) is 7.13% and return on invested capital (ROIC) is 1.83%.
| Return on Equity (ROE) | 7.13% |
| Return on Assets (ROA) | 1.06% |
| Return on Invested Capital (ROIC) | 1.83% |
| Return on Capital Employed (ROCE) | 3.56% |
| Revenue Per Employee | 725.80M |
| Profits Per Employee | 41.59M |
| Employee Count | 1,064 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 7.78 |
Taxes
In the past 12 months, HNX:HHC has paid 12.93 billion in taxes.
| Income Tax | 12.93B |
| Effective Tax Rate | 22.61% |
Stock Price Statistics
The stock price has decreased by -13.19% in the last 52 weeks. The beta is 0.25, so HNX:HHC's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -13.19% |
| 50-Day Moving Average | 115,852.00 |
| 200-Day Moving Average | 96,085.50 |
| Relative Strength Index (RSI) | 42.49 |
| Average Volume (20 Days) | 1,678 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:HHC had revenue of VND 772.25 billion and earned 44.25 billion in profits. Earnings per share was 2,694.16.
| Revenue | 772.25B |
| Gross Profit | 169.59B |
| Operating Income | 22.92B |
| Pretax Income | 57.18B |
| Net Income | 44.25B |
| EBITDA | 39.91B |
| EBIT | 22.92B |
| Earnings Per Share (EPS) | 2,694.16 |
Balance Sheet
The company has 64.83 billion in cash and 175.28 billion in debt, giving a net cash position of -110.44 billion or -6,724.12 per share.
| Cash & Cash Equivalents | 64.83B |
| Total Debt | 175.28B |
| Net Cash | -110.44B |
| Net Cash Per Share | -6,724.12 |
| Equity (Book Value) | 641.25B |
| Book Value Per Share | 39,040.98 |
| Working Capital | 399.55B |
Cash Flow
In the last 12 months, operating cash flow was -65.02 billion and capital expenditures -2.72 billion, giving a free cash flow of -67.73 billion.
| Operating Cash Flow | -65.02B |
| Capital Expenditures | -2.72B |
| Free Cash Flow | -67.73B |
| FCF Per Share | -4,123.83 |
Margins
Gross margin is 21.96%, with operating and profit margins of 2.97% and 5.73%.
| Gross Margin | 21.96% |
| Operating Margin | 2.97% |
| Pretax Margin | 7.40% |
| Profit Margin | 5.73% |
| EBITDA Margin | 5.17% |
| EBIT Margin | 2.97% |
| FCF Margin | n/a |
Dividends & Yields
HNX:HHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.69% |
| FCF Yield | -4.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNX:HHC has an Altman Z-Score of 5.1 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.1 |
| Piotroski F-Score | 4 |